In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan.
Show references:
https://doi.org/10.1016/s1474-4422(21)00159-9
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract